Study of TGM-312-SC01 in Healthy Participants and Adults With MASH

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Healthy Participants · MASH - Metabolic Dysfunction-Associated Steatohepatitis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Richmond Pharmacology, London, United Kingdom
Contact: Study coordinator (Study Director) · info@richmondpharmacology.com · +44 (0) 20 7042 5800

Study leads

Sponsor Medical Representative
Study Director
Tangram Therapeutics

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study to Investigate Safety, Tolerability, and Pharmacokinetics of AZD3974 in Healthy Participants

Healthy Participants

Abroad (travel likely)RecruitingPHASE1

Glendale, United States · Baltimore, United States

First-in-human Study of Orally Administered KT-579 in Healthy Adult Participants

Healthy Participants

Abroad (travel likely)RecruitingPHASE1

Lincoln, United States

A Study of IBI3032 in Healthy Participants

Healthy

Abroad (travel likely)RecruitingPHASE1

Lenexa, United States

Study of S-892216 Long-acting Injectable (LAI) in Healthy Adult Participants

Healthy Participants

Abroad (travel likely)RecruitingPHASE1

Lenexa, United States · Salt Lake City, United States